Table 2:
Variable |
AI Number (%) |
Chi-square (df; p) |
Exp (B) | Sig |
---|---|---|---|---|
Age | ||||
12–23 months | 28 (75.7) | 2.63 (1, 0.10) | 0.32 | 0.15 |
24–59 monthsa | 82 (87.2) | |||
Sex | ||||
Male | 58 (87.9) | 1.51 (1, 0.22) | 2.08 | 0.31 |
Femalea | 52 (80.0) | |||
Serostatus | ||||
HIV infected | 16 (88.9) | 0.37 (1, 0.54) | 0.38 | 0.49 |
HIV exposeda | 94 (83.2) | |||
Study district | ||||
Nadia | 23 (92.0) | 4.40 (3, 0.22) | 3.35 | 0.33 |
Murshidabad | 30 (75.0) | 0.57 | 0.61 | |
SPG | 30 (83.3) | 1.43 | 0.74 | |
NPGa | 27 (90.0) | |||
Mother on ART | ||||
Yes | 76 (81.7) | 1.21 (1, 0.27) | 0.07 | 0.07 |
Noa | 34 (89.5) | |||
Place of delivery | ||||
Government | 91 (84.3) | 11.85 (2, 0.003)** | 3.03 | 0.213 |
Private | 16 (100) | 594 | ||
Homea | 3 (42.9) | - | ||
Type of delivery | ||||
Vaginal | 70 (77.7) | 8.19 (1, 0.004)** | 0.143 | 0.069 |
LUCSa | 40 (97.6) | - | ||
Birth weight | ||||
<2.5 kg | 28 (84.8) | 0.04 (1, 0.83) | 0.77 | 0.76 |
≥2.5 kga | 76 (86.4) | |||
Place of vaccination | ||||
Government | 107 (86.3) | 0.41 (1, 0.523) | 2.6 | 0.55 |
Privatea | 3 (75.0) | |||
IPPI participation | ||||
Yes | 99 (85.3) | 1.42 (1, 0.23) | 8.17 | 0.07 |
Noa | 11 (73.3) | |||
Stigmatized by providers | ||||
Yes | 11 (55.0) | 14.72 (1, <0.001)** | 0.199 | 0.04* |
Noa | 99 (89.2) | - |
aReference category, *p < 0.05 **p < 0.01. LUCS: Lower uterine cesarean section, ART: Anti-retroviral therapy, AI: Adequately immunized, SPG: South 24 parganas district, NPG: North 24 parganas district, Sig: Significance, IPPI: Intensive pulse polio immunization, Exp (B): Exponential beta, df: Degrees of freedom, p: Probability.